tbuckley/cabot-search huggingface dataset:
Abstract P240: Neck Circumference is Associated with Carotid Intimal-media Thickness but Not with Coronary Artery Calcium: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Authors: Paulo A Lotufo, Cristina M Baena, Alessandra C Goulart, Itamar S Santos, Marcio S Bittencourt, Bruce B Duncan, Simin Liu, Isabela M Bensenor
Journal: Circulation (2016)

Introduction: Previously, we identified that neck circumference can be a risk indicator for common carotid intima-media thickness among people with low cardiovascular risk factors among participants of the ELSA-Brasil. One potential explanation should be an effect of perivascular fat in the neck on common carotid intima-media thickness. Hypothesis: we aim to compare the association of neck circumference with coronary artery calcium score and common carotid intima-media thickness in ELSA-Brasil. We hypothesized that a different pattern of association could reinforce the effect of local adiposity as a cause of atherosclerosis. Methods: In cross-sectional and sex-specific analyses of 2,266 women (50.6 ±8.4 yrs) and 1,886 men (50.7 ±9.0 yrs) with both common carotid intima-media thickness and coronary artery calcium score free from previous coronary heart disease at baseline, we built logistic models using diverse cut-off points for coronary artery calcium score score (0 vs. &gt;0, &lt;100 vs ≥100, &lt;400 vs ≥400 Agatston units) and common carotid intima-media thickness ( &lt; 75th percentile vs ≥75 th ; &lt; 90th percentile vs ≥90 th ) as dependent variables, after which adjustments for age and traditional cardiovascular risk factors were made. Results: Mean (standard deviation) neck circumference was 33.6 (±2.4 cm) for women and 38.8 (±2.6 cm) for men. In fully adjusted models including sociodemographic, cardiovascular risk factors and body-mass index (BMI) and waist circumference, for each 1 standard deviation increase in neck circumference we found an odds ratio (OR, 95% CI) for having common carotid intima-media thickness above the 75th percentile of (1.52, 1.16; 1.99) for women and (1.66, 1.28; 2.14) for men, and above the 90th common carotid intima-media thickness percentile [1.66 (1.19; 2.32)for men but not for women [1.21 (0.80; 1.82)]. We found no association between neck circumference and coronary artery calcium score using several different cut-off points (p&gt;0.05 for all). Conclusion: Neck circumference was significantly and independently associated with common carotid intima-media thickness but not with coronary artery calcium score in women and men, indicating a possible effect of perivascular fat tissue on atherosclerosis
IN VIVO MULTIGATED RADIONUCLIDE STUDIES OF THE ARTIFICIAL HEART: CASE REPORT.
Authors: A. Taylor, P. E. Christian, W. C. DeVries, F. L. Datz, L. Joyce
Journal: Clinical Nuclear Medicine (1983)

Taylor, A.; Christian, P. E.; DeVries, W. C.; Datz, F. L.; Joyce, L. Author Information
Update: Influenza Activity—United States and Worldwide, May-October 2004
Journal: JAMA (2005)

May-October 2004, influenza A (H3N2) viruses circulated worldwide and were associated with mild-to-moderate levels of disease activity. Influenza A (H1N1) and B viruses were reported less frequently. In North America, isolates of influenza A (H3N2), A (H1N1), and B were identified sporadically. This report summarizes influenza activity in the United States and worldwide during May-October 2004. Influenza activity in North America typically peaks during December-March.
Medical education in the United States. Introduction. I. Some recent events of special interest to medical education
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Sphingolipid Perturbations as Mechanisms for Fumonisin Carcinogenesis
Authors: Ronald T. Riley, Evaristus Enongene, Kenneth A. Voss, William P. Norred, Filmore I. Meredith, Raghubir P. Sharma, Jan Spitsbergen, David E. Williams, David B. Carlson, Alfred H. Merrill
Journal: Environmental Health Perspectives (2001)
Meeting of the International Society for Experimental Hematology
Journal: JNCI Journal of the National Cancer Institute (1976)

Journal Article Meeting of the International Society for Experimental Hematology Get access JNCI: Journal of the National Cancer Institute, Volume 56, Issue 2, February 1976, Page 453, https://doi.org/10.1093/jnci/56.2.453-c Published: 01 February 1976
Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk
Journal: Annals of Internal Medicine (1992)

▪ Objective: To identify echocardiographic predictors of arterial thromboembolism in patients with nonrheumatic atrial fibrillation and to determine whether these add to clinical variables for risk stratification. ▪ Design: Cohort study of patients assigned to placebo in a randomized clinical trial. ▪ Setting: Five hundred sixty-eight inpatients and outpatients with nonrheumatic atrial fibrillation assigned to placebo therapy at 15 U.S. medical centers from 1987 to 1989 in the Stroke Prevention in Atrial Fibrillation study. Patients were followed for a mean of 1.3 years. ▪ Measurements: M-mode and two-dimensional (2-D) echocardiograms performed at study entry and interpreted by local cardiologists. The predictive value of 14 echocardiographic variables for later ischemic stroke or systemic embolism was assessed by multivariate analysis. ▪ Main Results: Left ventricular dysfunction from 2-D echocardiograms (P = 0.003) and the size of the left atrium from M-mode echocardiograms (P = 0.02) were the strongest independent predictors of later thromboembolism. Multivariate analysis of these two independent echocardiographic predictors with the three independent clinical predictors of thromboembolism (history of hypertension, recent congestive heart failure, previous thromboembolism) identified 26% of the cohort with a low risk for thromboembolism (1.0% per year; 95% Cl, 0.2% to 4.0%). Compared with risk stratification using clinical variables alone, echocardiographic results altered thromboembolic risk stratification in 18% of the entire cohort and in 38% of those without clinical risk factors. ▪ Conclusions: Both left ventricular and left atrial variables are significant predictors of thromboembolism in patients with nonvalvular atrial fibrillation. Our results challenge traditional views of the pathogenesis of ischemic stroke in patients with atrial fibrillation and suggest that standard echocardiography contributes to risk stratification, differentiating the one third of patients without clinical risk factors who are at increased risk for stroke from the remainder who may not need antithrombotic prophylaxis.
Reversing vasectomy.
Authors: A. K. Banerjee, A. Simpson
Journal: BMJ (1992)

Advances in surgical techniques have made the reversal of vasectomy a realistic prospect. Currently, some 3% of patients request the reversal of vasectomy. Reversal techniques include macroscopic vasovasostomy, vasovasostomy with optical loupe magnification, and microsurgical methods. All of these methods have demonstrated acceptable rates of patency and pregnancy. Common to the success of these methods is the accurate apposition of mucosa to mucosa. The results of uniting the straight segments of the vas are better than those obtained with vasoepididymostomy. Recent reports indicate up to 80% patency and 30% pregnancy rates after macrosurgical anastomosis and up to 90% patency and 40% pregnancy rates after microsurgery. Operation failure could result from the following: poor anastomotic surgical technique, infection leading to fibrosis, formation of anastomotic sperm and suture granulomas, more than 10 years elapsing between the vasectomy and the reversal, and the removal of either too long a portion of the vas or part of the convoluted portion of the vas during the initial vasectomy. Although uncommon, some complications during the reversal procedure have been reported. As the reports indicate, pregnancy and patency differ significantly. Several explanations exist: 1) semen quality after reversal may be poor; 2) a secondary anastomotic stricture in the vas may gradually develop; 3) pressure mediated local changes may affect the testis and epididymis; 4) there might be a an injury to the sympathetic nerve fibers in the vas sheath; 5) antibodies to sperm may be present. While reversal is possible, the article cautions that the public should not consider vasectomy a reversible method of birth control.
Regulation
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Phase 3, Randomised, Double-Blind, Placebo-Controlled, International Study of Medi4736 in Patients with Locally Advanced, Unresectable, Stage 3 Nsclc Who Have not Progressed Following Platinum-Based, Concurrent Chemoradiation Therapy (PACIFIC)
Authors: B. Creelan, N.O. Iannotti, M.A. Salamat, D. Jayawardene, M. Ballas, P.K. Stockman, S.J. Antonia
Journal: Annals of Oncology (2015)
Diseases of the Organs of Respiration. A Treatise on the Etiology, Pathology, Symptoms, Diagnosis, Prognosis and Treatment of the Diseases of the Lungs and Air-Passages by Samuel West, M.A., M.D., F.R.C.P,. Assistant Physician and Lecturer on the Principles and Practice of Medicine at St. Bartholomew's Hospital.
Journal: JAMA (1902)

This is a work on which the author has spent many years, and he has endeavored to include within its scope most diseases of the larynx, and practically all diseases of the trachea, bronchi, lungs and pleura. In this he has been very successful, having devoted considerable space not only to the ordinary diseases of these organs, but also to such affections as interlobular emphysema, septic embolic and hematogenous pneumonia; pulmonary infarct, embolism, and thrombosis; hysteric neuroses, diaphragmatic hernia, hernia of the lungs, syphilis of the lungs and pleura, actinomycosis, aspergillosis and coccidiosis of the lungs; hydatids and new growths of the lungs and pleura. The various diseases are treated as concisely as practicable, considering the relative importance of each subject. The author's style is terse and clear. He has not hesitated throughout the book to express his own opinions, but they have been founded on long and extensive experience
Renal function after pituitary ablation for diabetic retinopathy
Authors: M. Isaacs
Journal: JAMA (1969)

Renal function was evaluated in 18 patients before and after pituitary ablation for diabetic retinopathy. Prior to therapy, blood urea nitrogen levels were below 20 mg/100 ml in 11 and above 25 mg/100 ml in only 1 of the 18. Glomerular filtration rate was low in 16 of these patients, and renal plasma flow was reduced in nine of the 11 patients measured. After ablation, glomerular filtration rate or renal plasma flow, or both, were further decreased in 16. Control total exchangeable potassium (TEK) was normal in 15 of 22 patients. After therapy, the TEK decreased in 16 of 20 patients. Percutaneous renal biopsy specimens were obtained in six patients before therapy, all six specimens revealed nodular glomerulosclerosis and arteriolar sclerosis. No additional changes or regression of lesions were noted in any postablation renal biopsy specimen.
MICHIGAN MEDICAL LAWS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
On Rous, Leucotic and Allied Tumours in the Fowl. A Study in Malignancy.
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Rhesus diploid rabies vaccine (adsorbed), a new rabies vaccine. Results of initial clinical studies of preexposure vaccination
Authors: B. S. Berlin
Journal: JAMA (1982)

To meet the need for a safe, efficacious, and low-cost rabies vaccination program, the Michigan Department of Public Health developed a new rabies vaccine: rhesus diploid rabies vaccine, adsorbed (RDRV). Initial clinical studies were conducted in 534 volunteers using preexposure protocols consisting of two injections of RDRV given 1, 2, or 4 weeks apart. This new rabies vaccine induced an excellent rabies virus antibody response two to three weeks after vaccination: antibody levels were superior to those reported after duck embryo rabies vaccine and were similar to those reported with human diploid rabies vaccine. In addition, vaccination with RDRV was associated with an acceptable level of local and constitutional symptoms. (<i>JAMA</i>1982;247:1726-1728)
Barbiturates and barbiturate-like drugs. Considerations in their medical use
Journal: JAMA (1974)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
INFLAMMATORY AFFECTIONS OF THE COSTAL CARTILAGES.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The NF-κB Negative Regulator TNFAIP3 (A20) is Commonly Inactivated by Somatic Mutations and Genomic Deletions in Marginal Zone B-Cell Lymphomas
Authors: Urban Novak, Andrea Rinaldi, Ivo Kwee, Subhadra V. Nandula, Paola M.V. Rancoita, Mara Compagno, Michaela Cerri, Davide Rossi, Vundavalli V. Murty, Emanuele Zucca, Gianluca Gaidano, Riccardo Dalla-Favera, Laura Pasqualucci, Francesco Bertoni, Govind Bhagat
Journal: Blood (2008)
MALARIA IN THE SOUDAN.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Daubert v Merrell Dow
Authors: Jay A. Gold
Journal: JAMA (1993)

ON JUNE 28, 1993, the US Supreme Court handed down a decision that, in the words of one commentator, "could affect almost every piece of litigation in the Federal courts from this point forward."<sup>1</sup>The decision in<i>Daubert v Merrell Dow Pharmaceuticals</i><sup>2</sup>sets forth criteria that federal courts must follow in admitting scientific evidence or excluding it from consideration by juries. While the decision will not apply directly to state courts, states are likely to look to the High Court for guidance. This article will analyze the decision and discuss its implications for medicine, medical publishing, and expert testimony. <h3>THE CASE</h3> The drug for morning sickness, Bendectin (doxylamine), was driven off the market in 1983 by the pressure of lawsuits asserting that it caused birth defects. Before Bendectin was taken off the market, millions of women had used it.<sup>3</sup>Of 30 published epidemiologic studies involving over 130